Michael is a Senior Business Development Manager in the Faculty of Medicine at Monash University. He has over 20 years of experience in both life science research and technology commercialisation. His commercial roles have been predominantly focused on the identification, development, project management and commercialisation of academically derived opportunities. Prior to joining Monash, Michael was an Investment Manager and CEO at Trans-Tasman Fund Management Pty Ltd (TTFM), a fund management company that managed over $30 million in seed and venture capital and specialised in investments from the academic sector in Australia and New Zealand. At TTFM Michael managed the Life Science portfolio and led due diligence on numerous opportunities, including Nexvet Biopharma Pty. Ltd. (AU) and Heart Metabolics (UK) - where Michael was appointed as a Director. Prior to joining TTFM, Michael was a 'Roche Research Foundation' Post-Doctoral fellow at the Swiss Experimental Cancer Research Institute (ISREC) in Lausanne, Switzerland. Michael holds a first class honours degree and PhD in developmental and stem cell biology from the University of Adelaide and an MBA from La Trobe University, specialising in technology management.

Email: michael dot bettess at monash dot edu